According to SuperPred, temoporfin may interact with five melanoma targets: DNA (apurinic or apyrimidinic site) lyase, beta-1 adrenergic receptor, C-X-C chemokine receptor type 4, galectin-3, and toll-like receptor 8. Here, CXCR4 is linked to melanoma.